🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Hereditary Pheochromocytoma Assessment of Tumour Immunologies

Recruitingn/aAges 18 Years - anyAllRadboud University Medical Center
NCT06444607 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this study, the investigators are examining the role of the immune system in pheochromocytoma and paraganglioma. The investigators aim to examine the differences in the immune system between people who have these tumors with and without a hereditary predisposition. The investigators also want to see how the immune system changes during the development of the tumor in people with a hereditary predisposition. Finally, the investigators will compare the data with a control group of people without these tumors. Ultimately, the investigators hope that the results will contribute to the discovery of new immune system-targeted medications for pheochromocytoma and paraganglioma.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Part I: * Newly diagnosed patients with PPGL or newly diagnosed patients with (metastatic) PPGL recurrence. * OR patients with mutations which predispose for the development of PPGL. * Aged \> 18 years. Part II: * Confirmed PPGL on pathology. * Aged \> 18 years. Exclusion Criteria: * Unable to provide informed consent. * Active inflammatory or infectious comorbidities. * Other malignancies which are under active treatment (except for basal cell carcinoma, other in situ carcinomas). * Using medication interfering with the immune system * Pregnancy or breastfeeding * A self-reported alcohol consumption of \>21 units per week
💊

What it tests

  • Venepuncture
  • Venepuncture
📍

Where

1 site
Radboudumc
Nijmegen, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy